Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Finch, G. L.
Right arrow Articles by Hobbs, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finch, G. L.
Right arrow Articles by Hobbs, C. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal Article

Carcinogenic Responses of Transgenic Heterozygous p53 Knockout Mice to Inhaled 239PuO2 or Metallic Beryllium

Gregory L. Finch

Inhalation Toxicology Laboratory, Lovelace Biomedical and Environmental Research Institute, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185

Thomas H. March

Inhalation Toxicology Laboratory, Lovelace Biomedical and Environmental Research Institute, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185

Fletcher E. Hahn

Inhalation Toxicology Laboratory, Lovelace Biomedical and Environmental Research Institute, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185

Edward B. Barr

Inhalation Toxicology Laboratory, Lovelace Biomedical and Environmental Research Institute, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185

Steven A. Belinsky

Inhalation Toxicology Laboratory, Lovelace Biomedical and Environmental Research Institute, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185

Mark D. Hoover

Inhalation Toxicology Laboratory, Lovelace Biomedical and Environmental Research Institute, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185

John E. Lechner

Inhalation Toxicology Laboratory, Lovelace Biomedical and Environmental Research Institute, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185

Kristen J. Nikula

Inhalation Toxicology Laboratory, Lovelace Biomedical and Environmental Research Institute, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185

Charles H. Hobbs

Inhalation Toxicology Laboratory, Lovelace Biomedical and Environmental Research Institute, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185

The transgenic heterozygous p53+/- knockout mouse has been a model for assessing the tumorigenicity of selected carcinogens administered by noninhalation routes of exposure. The sensitivity of the model for predicting cancer by inhaled chemicals has not been examined. This study addresses this issue by acutely exposing p53+/- mice of both sexes by nose-only inhalation to either air (controls), or to 1 of 2 levels of 239PuO2 (500 or 100 Bq 239Pu) or beryllium (Be) metal (60 or 15 µg). Additional wild-type p53+/- mice were exposed by inhalation to either 500 Bq of 239PuO2 or 60 µg of Be metal. These carcinogens were selected because they operate by differing mechanisms and because of their use in other pulmonary carcinogenesis studies in our laboratory. Four or 5 of the 15 mice per sex from each group were sacrificed 6 mo after exposure, and only 2 pulmonary neoplasms were observed. The remainder of the mice were held for life-span observation and euthanasia as they became moribund. Survival of the p53+/- knockout mice was reduced compared to the p53+/+ wild-type mice. No lung neoplasms were observed in p53+/- mice exposed to air alone. Eleven of the p53+/- mice inhaling 239PuO2 developed pulmonary neoplasms. Seven p53+/+ mice exposed to 239PuO2 also developed pulmonary neoplasms, but the latency period for pulmonary neoplasia was significantly shorter in the p53+/- mice. Four pulmonary neoplasms were observed in p53+/- mice exposed to the higher dose of Be, whereas none were observed in the wild-type mice or in the heterozygous mice exposed to the lower dose of Be. Thus, both p53+/- and p53+/+ mice were susceptible to 239Pu-induced carcinogenesis, whereas the 53+/- but not the p53+/+ mice were susceptible to Be-induced carcinogenesis. However, only 2 pulmonary neoplasms (1 in each of the 239PuO2 exposure groups) were observed in the 59 p53+/- mice that were sacrificed or euthanatized within 9 mo after exposure, indicating that the p53+/- knockout mouse might not be appropriate for a 6-mo model of carcinogenesis for these inhaled carcinogens.

Key Words: Inhalation exposure • acute exposure • lung • pulmonary neoplasm • cancer incidence • latency • carcinogenesis • survival • mice • transgenic • p53 tumor suppressor gene

Toxicologic Pathology, Vol. 26, No. 4, 484-491 (1998)
DOI: 10.1177/019262339802600404


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
S. R. Payne and C. J. Kemp
p27 Kip1 (Cdkn1b)-Deficient Mice Are Susceptible to Chemical Carcinogenesis and May Be a Useful Model for Carcinogen Screening
Toxicol Pathol, June 1, 2003; 31(4): 355 - 363.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
N. Shirai, T. Tsukamoto, M. Yamamoto, T. Iidaka, H. Sakai, T. Yanai, T. Masegi, L. A. Donehower, and M. Tatematsu
Elevated susceptibility of the p53 knockout mouse esophagus to methyl-N-amylnitrosamine carcinogenesis
Carcinogenesis, September 1, 2002; 23(9): 1541 - 1547.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
Y. Mori, A. Koide, K. Fuwa, H. Wanibuchi, and S. Fukushima
Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53(+/-) knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine
Mutagenesis, September 1, 2001; 16(5): 377 - 383.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. D. Storer, J. E. French, J. Haseman, G. Hajian, E. K. Legrand, G. G. Long, L. A. Mixson, R. Ochoa, J. E. Sagartz, and K. A. Soper
p53 +/- Hemizygous Knockout Mouse: Overview of Available Data
Toxicol Pathol, January 1, 2001; 29(1_suppl): 30 - 50.
[Abstract] [PDF]


Home page
Toxicol SciHome page
D. A. Delker, B. L. Yano, and B. B. Gollapudi
Evaluation of Cytotoxicity, Cell Proliferation, and Genotoxicity Induced by p-Cresidine in Hetero- and Nullizygous Transgenic p53 Mice
Toxicol. Sci., June 1, 2000; 55(2): 361 - 369.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
D. Gulezian, D. Jacobson-Kram, C. B. Mccullough, H. Olson, L. Recio, D. Robinson, R. Storer, R. Tennant, J. M. Ward, and D. A. Neumann
Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment
Toxicol Pathol, May 1, 2000; 28(3): 482 - 499.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
R. R. Maronpot
The Potential of Genetically Altered Mice as Animal Models for Carcinogen Identification
Toxicol Pathol, July 1, 1998; 26(4): 579 - 581.
[PDF]